The Effectiveness of Giving the COVID-19 Vaccine in Pregnancy
DOI:
https://doi.org/10.53017/ujhs.76Keywords:
Effectiveness, Covid-19 Vaccine, PregnancyAbstract
The period of pregnancy is very vulnerable to transmission of various kinds of viral infections, including the Corona Virus that is currently spreading in Indonesia. One of the efforts to prevent contracting the COVID-19 virus is the administration of the COVID-19 vaccine. The purpose of this study was to determine the effectiveness and safety of administering the COVID-19 vaccine during pregnancy. The method in this study uses a literature review of 17 journals or articles that discuss vaccines in pregnancy. Based on the results of a literature review from 17 articles related to the effectiveness and safety of the COVID-19 vaccine, it shows that vaccination in pregnancy can provide protection for the mother and fetus. In general, the vaccine does not cause growth and development disorders in the fetus, if given at least 12 weeks of gestation or entering the second trimester, Side effects after vaccination only have mild symptoms such as fever and pain at the injection site. The harmful side effects are unknown and still need further research. To increase the scope and target of COVID-19 vaccination, it is expected that health workers or health cadres will provide health counseling/education about the effectiveness and safety of the COVID-19 vaccine, the need for cross-sectoral collaboration and support from government officials in this case the health department.
Downloads
References
I. A. Stafford, J. G. Parchem, and B. M. Sibai, “The coronavirus disease 2019 vaccine in pregnancy: risks, benefits, and recommendations,” Am. J. Obstet. Gynecol., vol. 224, no. 5, pp. 484–495, 2021.
D. Lv et al., “Exploring the Immunopathogenesis of Pregnancy With COVID-19 at the Vaccination Era,” Front. Immunol., vol. 12, no. July, pp. 1–6, 2021.
P. K. Kesehatan, “Data positif berdasarkan provinsi, jenis kelamin, usia, gejala, dan komorbid bersumber dari update,” 2021.
Haryanti Puspa Sari, “Kasus Coovid-19 pada Ibu Hamil Meningkat, Mayoritas Tanpa Gejala,” 2021. [Online]. Available: https://nasional.kompas.com/read/2021/07/02/10455881/pogi-kasus-covid-19-pada-ibu-hamil-meningkat-mayoritas-tanpa-gejala. .
S. Kashte, A. Gulbake, S. F. El-Amin, and A. Gupta, “COVID-19 vaccines: rapid development, implications, challenges and future prospects,” Hum. Cell, vol. 34, no. 3, pp. 711–733, 2021.
H. Gencer, S. Özkan, and O. Vardar, “Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information ,” no. January, 2020.
C. Indonesia, “Manfaat Vaksin Covid-19 Ibu Hamil , Bantu Janin Dapat Antibodi,” 2021. [Online]. Available: https://www.cnnindonesia.com/gaya-hidup/20210803100847-255-675647/manfaat-vaksin-covid-19-ibu-hamil-bantu-janin-dapat-antibodi.%0A%0A.
K.Kesehatan,“Surat_Edaran_Tentang_Vaksinasi_COVID 19_Bagi_Ibu_Hamil_dan_Penyesuaian_Skrinning_dalam_Pelaksanaan_Vaksinasi_COVID-19.pdf,” vol. 4247608, no. 021, p. 6, 2021.
Antara, “3.581 ibu Hamil di Kudus Jadi Sasaran Vaksinasi Covid -19,” 2021. [Online]. Available: https://www.medcom.id/nasional/daerah/4KZ2MrJK-3-518-ibu-hamil-di-kudus-jadi-sasaran-vaksinasi-covid-19.
J. Allotey et al., “Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis,” BMJ, vol. 370, 2020.
E. W. Wang, J. G. Parchem, R. L. Atmar, and E. H. Clark, “SARS-CoV-2 Vaccination During Pregnancy: A Complex Decision,” Open Forum Infect. Dis., vol. 8, no. 5, pp. 1–6, 2021.
M. Skjefte et al., “COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries,” Eur. J. Epidemiol., vol. 36, no. 2, pp. 197–211, 2021.
A. I. Mazur-Bialy, D. Ko?oma?ska-Bogucka, S. Tim, and M. Op?awski, “Pregnancy and Childbirth in the COVID-19 Era—The Course of Disease and Maternal–Fetal Transmission,” J. Clin. Med., vol. 9, no. 11, p. 3749, 2020.
Z. Saeed, O. Greer, and N. M. Shah, “Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?,” Antibodies, vol. 9, no. 3, p. 38, 2020.
M. Sebghati and A. Khalil, “Uptake of vaccination in pregnancy,” Best Pract. Res. Clin. Obstet. Gynaecol., no. January, 2021.
D. B. Fell et al., “Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information ,” no. January, 2020.
R. Farrell, M. Michie, and R. Pope, “Pregnant Women in Trials of Covid-19: A Critical Time to Consider Ethical Frameworks of Inclusion in Clinical Trials,” Ethics Hum. Res., vol. 42, no. 4, pp. 17–23, 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 N Nasriyah, I Islami, Nor Asiyah
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
